Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes
Next Steps for #T2DM with Low #Cardiovascular Risk: older generic or biosimilar low-cost agents still have a role in the treatment of persons with early #T2DM who are at low #cardiovascularrisk